Loading...

A Phase 1, Multiple-Dose, Open-Label, Randomized, 3-Period Crossover Study to Evaluate the Effect of SYR-322 on the Pharmacokinetics of Digoxin in Healthy Subjects - Vivli | NLM Dataset Catalog